Sort
261,768 grants matching “gene therapy”
DCTD Biopharmaceutical Development
$9,577,323David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
Clinical Research and Protocol Support Services
$9,561,789William O'Donnell · National Eye Institute · ZID · FY2023 · EY
Helping to End Addiction Long-term (HEAL): Development of Clinical Candidate Drugs for Pain, Addiction and Overdose
$9,556,745Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
DCTD Biopharmaceutical Development
$9,525,000Larry Arthur · Leidos Biomedical Research, Inc. · N01 · FY2010 · CA
Institute of Translational Health Sciences
$9,405,183Mary L. Disis · University Of Washington · UL1 · FY2017 · TR
Defense against Biowarfare and Emerging Infection Agents
$9,378,104Myron Max Levine · University Of Maryland Baltimore · U54 · FY2006 · AI
ASPirin in Reducing Events in the Elderly
$9,375,981Richard H Grimm · Hennepin Healthcare Research Institute · U01 · FY2010 · AG
Institute of Translational Health Sciences
$9,374,914Mary L. Disis · University Of Washington · UL1 · FY2019 · TR
REGIONAL PRIMATE RESEARCH CENTER
$9,366,642Oregon Health And Science University · P51 · FY2001 · RR
NCATS-DPI-22-0101 - CREATION OF AN OPEN-SOURCE PROCESS TO MANUFACTURE AAV VECTOR-BASED GENE THERAPY CANDIDATES FOR NON-COMMERCIAL CLINICAL STUDIES
$9,308,321Venkata Mangalampalli · Leidos Biomedical Research, Inc. · N01 · FY2022 · CA
Abramson Cancer Center Support Grant
$9,300,603Robert H Vonderheide · University Of Pennsylvania · P30 · FY2025 · CA
UC Irvine MODEL-AD
$9,281,325Frank M Laferla · University Of California-Irvine · U54 · FY2025 · AG
UC Irvine MODEL-AD
$9,263,803Frank M Laferla · University Of California-Irvine · U54 · FY2024 · AG
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
$9,232,051Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2002 · CA
UC Irvine MODEL-AD
$9,231,507Frank M Laferla · University Of California-Irvine · U54 · FY2023 · AG
Abramson Cancer Center Support Grant
$9,230,603Robert H Vonderheide · University Of Pennsylvania · P30 · FY2024 · CA
Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents
$9,156,561Lindsay Morton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
Defense against Biowarfare and Emerging Infection Agents
$9,124,674University Of Maryland Baltimore · U54 · FY2004 · AI
UC Irvine MODEL-AD
$9,067,709Frank M Laferla · University Of California-Irvine · U54 · FY2022 · AG
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
$9,040,833Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2003 · CA
Abramson Cancer Center Support Grant
$9,040,646Robert H Vonderheide · University Of Pennsylvania · P30 · FY2023 · CA
Defense against Biowarfare and Emerging Infection Agents
$9,038,291Myron Max Levine · University Of Maryland Baltimore · U54 · FY2008 · AI
Adoptive Cell Transfer Immunotherapy of Cancer
$9,021,401Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Gene therapy of cancer
$9,021,401Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
$9,012,593Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2000 · CA